Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
January 2021
Kira Pharmaceuticals raises a $53,500,000 series B round from APlus Partners, Foresite Capital, QiMing Venture Partners, Quan Capital, RA Capital Management and Vivo Capital.
November 2020
Kira Pharmaceuticals raises a $46,000,000 series A round from 6 Dimensions Capital, QiMing Venture Partners, Quan Capital and Sinopharm Capital.
Funding rounds
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
Kira Pharmaceuticals
February 23, 2021
www.prnewswire.com:443
/PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated...
Is a
CompanyCompany attributes
Crunchbase
Foresite Capital
Vivo Capital
QiMing Venture Partners
RA Capital Management
6 Dimensions Capital
Quan Capital
Sinopharm CapitalTotal funding amount (USD)
99,500,000
Latest funding round date
January 2021
Latest funding type
Series B round